Inhibition of endogenous nitric oxide synthase augments contractile response to adenylyl cyclase stimulation without altering mechanical efficiency in patients with idiopathic dilated cardiomyopathy.

BACKGROUND Increased nitric oxide (NO) in the failing heart attenuates the myocardial contractile response to beta-adrenergic receptor stimulation. However, the physiological effects of NO on the beta-adrenergic post-receptor signaling system are unknown. The objective of the present study was to examine the effects of cardiac NO synthase (NOS) inhibition on left ventricular (LV) hemodynamics and mechanoenergetics in response to adenylyl cyclase stimulation in human heart failure. METHODS AND RESULTS The study group comprised 13 patients with heart failure because of idiopathic cardiomyopathy (IDC). Emax was examined as an index of LV contractility, LV external work (EW), pressure-volume area (PVA), myocardial oxygen consumption (MVO2), and mechanical efficiency (EW/MVO2) with the use of conductance and coronary sinus thermodilution catheters before and during colforsin daropate infusion, and during concurrent infusion of colforsin daropate with the NOS inhibitor, NG-monomethyl-L-arginine (L-NMMA; 200 micromol). Colforsin daropate increased Emax by 53% and EW by 18%, and reduced PVA by 14%, without altering MVO2 or mechanical efficiency. The combination of colforsin daropate with L-NMMA further increased Emax by 26% and reduced PVA by 9%, without altering MVO2 or mechanical efficiency. CONCLUSIONS These findings suggest endogenous NO may modulate beta-adrenergic post-receptor pathways and preserve myocardial efficiency in patients with IDC.

[1]  F. Wei,et al.  Ischemic preconditioning attenuates postischemic leukocyte--endothelial cell interactions: role of nitric oxide and protein kinase C. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[2]  J. Balligand,et al.  Nitric Oxide and the Heart: Update on New Paradigms , 2005, Annals of the New York Academy of Sciences.

[3]  S. Yoshifuku,et al.  Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[4]  J. Balligand,et al.  Update on New Paradigms , 2005 .

[5]  T. Myrmel,et al.  Nitric oxide synthase inhibition impairs myocardial efficiency and ventriculo‐arterial matching in acute ischemic heart failure , 2004, European journal of heart failure.

[6]  P. Insel,et al.  Nitric Oxide Inhibition of Adenylyl Cyclase Type 6 Activity Is Dependent upon Lipid Rafts and Caveolin Signaling Complexes* , 2004, Journal of Biological Chemistry.

[7]  S. Houser,et al.  Myocyte Nitric Oxide Synthase 2 Contributes to Blunted β-Adrenergic Response in Failing Human Hearts by Decreasing Ca2+ Transients , 2004, Circulation.

[8]  J. Balligand,et al.  Nitric Oxide and Cardiac Function: Ten Years After, and Continuing , 2003, Circulation research.

[9]  A. Shoukas,et al.  Nitric Oxide Regulation of Myocardial Contractility and Calcium Cycling: Independent Impact of Neuronal and Endothelial Nitric Oxide Synthases , 2003 .

[10]  K. Hashimoto,et al.  Cardiovascular and adenylate cyclase stimulating effects of colforsin daropate, a water-soluble forskolin derivative, compared with those of isoproterenol, dopamine and dobutamine. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[11]  Takashi Sugamori,et al.  Increased nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy: close correlation of tumor necrosis factor-alpha with systemic and local production of nitric oxide. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. , 2002 .

[13]  D. Kass,et al.  Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart , 2002, Circulation research.

[14]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms , 2002, Nature.

[15]  D. Kass,et al.  cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. , 2000, American journal of physiology. Heart and circulatory physiology.

[16]  D. Kass,et al.  Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. , 2000, Circulation research.

[17]  MitsuhiroYokoyama,et al.  Nitric Oxide Spares Myocardial Oxygen Consumption Through Attenuation of Contractile Response to β-Adrenergic Stimulation in Patients With Idiopathic Dilated Cardiomyopathy , 2000 .

[18]  T. Shinke,et al.  Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy. , 2000, Circulation.

[19]  M. Creager,et al.  Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. , 1998, Circulation.

[20]  I. Belenkie,et al.  Diastolic ventricular interaction in chronic heart failure , 1997, The Lancet.

[21]  X. Xu,et al.  ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. , 1997, Circulation.

[22]  M. Creager,et al.  Nitric Oxide Inhibits the Positive Inotropic Response to β-Adrenergic Stimulation in Humans With Left Ventricular Dysfunction , 1995 .

[23]  R. Walsh,et al.  Mechanisms, diagnosis, and treatment of diastolic heart failure. , 1995, American heart journal.

[24]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[25]  P. Macdonald,et al.  Increased nitric oxide production in heart failure , 1994, The Lancet.

[26]  M. Yokoyama,et al.  Effect of NKH477, a new water-soluble forskolin derivative, on arterial-ventricular coupling and mechanical energy transduction in patients with left ventricular systolic dysfunction: comparison with dobutamine. , 1994, Journal of cardiovascular pharmacology.

[27]  R Fischmeister,et al.  Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.

[28]  M. Yokoyama,et al.  Comparison of Hemodynamic Determinants for Myocardial Oxygen Consumption Under Different Contractile States in Human Ventricle , 1993, Circulation.

[29]  T. Itoh,et al.  Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery. , 1992, Circulation research.

[30]  G. Baumann,et al.  Cardiovascular Effects of Forskolin (HL 362) in Patients with Idiopathic Congestive Cardiomyopathy—A Comparative Study with Dobutamine and Sodium Nitroprusside , 1990, Journal of cardiovascular pharmacology.

[31]  H Suga,et al.  Ventricular energetics. , 1990, Physiological reviews.

[32]  R Beyar,et al.  Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. , 1989, Circulation.

[33]  W. Schmitz,et al.  INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILURE , 1988, The Lancet.

[34]  K. Sagawa,et al.  Optimal Arterial Resistance for the Maximal Stroke Work Studied in Isolated Canine Left Ventricle , 1985, Circulation research.

[35]  D. Harrison,et al.  Simultaneous measurement of coronary venous blood flow and oxygen saturation during transient alterations in myocardial oxygen supply and demand. , 1982, The American journal of cardiology.

[36]  Hook Eb,et al.  Abortions because of unavailability of prenatal diagnosis. , 1981 .

[37]  W Grossman,et al.  Contractile State of the Left Ventricle in Man as Evaluated from End‐systolic Pressure‐Volume Relations , 1977, Circulation.